This is the fifth volume in the series entitled New Cardiovascular Drugs, which is an annual
work consisting of review articles on contemporary new agents considered for use as drugs …

Ischemic heart disease is one of the most dreaded clinical conditions since the mortality and
morbidity rates associated with it are very high. It is a medical emergency, and thus needs …

NEWS OF CONGRESS OF AMERICAN HEART ASSOCIATION | Martsevich | Rational
Pharmacotherapy in Cardiology Rational Pharmacotherapy in Cardiology Rational …

The European Society of Cardiology (ESC) Working Group (WG) on Cardiovascular
Pharmacotherapy works with all aspects of cardiovascular pharmacotherapy: From basic …

A review of all the drugs used in the treatment of cardiovascular disorders was outside the
scope of this chapter. Those selected are important in terms of the number of patients treated …

This book is the outcome of a cardiologist switching to clinical pharma cology in mid-career
and may be seen as representing the interface between the two disciplines. In this second …

Clinical trial design inclusion criteria typically require that patients be on optimal medical
therapy prior to their enrollment or randomization, ie, they are currently being managed by …

ischemic heart disease is the leading cause at the present, this thesis demonstrates the risk
factors of the disorders, possible ways to prevent it as well as the therapeutic aspects …